61.43
price down icon3.67%   -2.34
pre-market  Pre-mercato:  61.43  
loading

ANI Pharmaceuticals Inc Borsa (ANIP) Ultime notizie

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension - GlobeNewswire

pulisher
GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

pulisher
GlobeNewswire Inc.

Muthusamy Shanmugam Sells 5836 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - Defense World

pulisher
Defense World

Renee P. Tannenbaum Sells 2000 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - Defense World

pulisher
Defense World

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 14850 Shares - Defense World

pulisher
Defense World

Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 16669 Shares of Stock - Defense World

pulisher
Defense World

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Director Renee Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals Inc (ANIP) - Yahoo Finance Australia

pulisher
Yahoo Finance Australia

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com

pulisher
Investing.com

Ani Pharmaceuticals executive sells over $2.3 million in company stock - Investing.com Australia

pulisher
Investing.com Australia

Ani Pharmaceuticals executive sells over $2.3 million in company stock - Investing.com Canada

pulisher
Investing.com Canada

Ani Pharmaceuticals executive sells over $2.3 million in company stock - Investing.com

pulisher
Investing.com

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com UK

pulisher
Investing.com UK

Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week

pulisher
Zacks Investment Research

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

pulisher
Zacks Investment Research

J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition

pulisher
Zacks Investment Research

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

pulisher
Zacks Investment Research

New York State Common Retirement Fund Has $313000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World

pulisher
Defense World

Renee P. Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - MarketBeat

pulisher
MarketBeat

ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Yahoo Singapore News

pulisher
Yahoo Singapore News

Ani Pharmaceuticals CEO sells shares worth over $1.1 million - Investing.com South Africa

pulisher
Investing.com South Africa

Will ANI Pharmaceuticals (ANIP) Continue to Surge Higher? - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 16,669 Shares of Stock - MarketBeat

pulisher
MarketBeat

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP) - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

Ani Pharmaceuticals CEO sells shares worth over $1.1 million - Investing.com

pulisher
Investing.com

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

pulisher
Zacks Investment Research

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

pulisher
Zacks Investment Research

Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion

pulisher
Zacks Investment Research

ANI Pharmaceuticals Down 25% After Earnings Miss - Yahoo News UK

pulisher
Yahoo News UK

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

pulisher
Zacks Investment Research

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why - Yahoo Lifestyle Australia

pulisher
Yahoo Lifestyle Australia

ANI Pharmaceuticals (NASDAQ:ANIP) PT Raised to $87.00 at HC Wainwright - Defense World

pulisher
Defense World

ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 51% On Their Shares - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

ANI Pharmaceuticals Financial Health Overview Released - TipRanks.com - TipRanks

pulisher
TipRanks

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

pulisher
Zacks Investment Research

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

pulisher
Zacks Investment Research

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

pulisher
Zacks Investment Research

Ani Pharmaceuticals executive sells $16.9k in stock - Investing.com India

pulisher
Investing.com India

ANI Pharmaceuticals shares target raised by H.C. Wainwright on strong Q1 performance - Investing.com India

pulisher
Investing.com India

Ani Pharmaceuticals executive sells $16.9k in stock By Investing.com - Investing.com

pulisher
Investing.com

ANI Pharmaceuticals (NASDAQ:ANIP) PT Raised to $87.00 - MarketBeat

pulisher
MarketBeat

Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag

pulisher
Zacks Investment Research

ANI Pharmaceuticals shares target raised by H.C. Wainwright on strong Q1 performance - Investing.com

pulisher
Investing.com

Investors in ANI Pharmaceuticals (NASDAQ:ANIP) have seen respectable returns of 85% over the past three years - Simply Wall St

pulisher
Simply Wall St

ANI Pharmaceuticals Down 25% After Earnings Miss - Yahoo News UK

pulisher
Yahoo News UK

ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next - Yahoo Finance

pulisher
Yahoo Finance

Meredith Cook Sells 250 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - MarketBeat

pulisher
MarketBeat

ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run? - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Thompson Siegel & Walmsley LLC Sells 15796 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat

pulisher
MarketBeat
$79.67
price down icon 1.76%
$17.19
price up icon 1.24%
$55.37
price up icon 0.22%
drug_manufacturers_specialty_generic RDY
$68.26
price down icon 1.50%
$142.29
price up icon 0.27%
$10.98
price down icon 0.36%
Capitalizzazione:     |  Volume (24 ore):